Facts, collaboration, and open minds can solve one of society’s most pressing issues.
Jacek Olczak, Chief Operating Officer
This will be a year of important decisions on how to rebuild, reset, and address the many challenges ahead. And while the response to our most immediate challenge—the global COVID-19 pandemic—is far from perfect or complete, it underscores an immense potential for progress that cannot be overlooked.
A remarkable mobilization among scientists, governments, the public health community, and businesses achieved something that no one would have thought to be possible before: the development and distribution of vaccines for a newly discovered virus, in less than a year. To be sure, important issues remain in terms of global access and deployment, along with a pressing need to address misinformation and distrust. But these can’t diminish this incredible feat, which should serve as a reminder of how far we can go when science prevails and everyone works together with a sense of urgency and a common purpose.
Could this example inspire a new approach in addressing other global challenges? I certainly hope it will, considering the size and complexity of the issues ahead of us. Reaffirming the magnitude of the task at hand, 22,507 respondents in an international survey conducted in December 2020 by research firm Povaddo and commissioned by Philip Morris International (PMI), indicated that the public supports governments dedicating time and resources toward matters ranging from improving the economy and ensuring better healthcare for all, to combating climate change and reducing smoking rates.
As far as addressing smoking is concerned, from my position at PMI, I know for a fact that there’s significant opportunity for progress. We have transformed our business to deliver a smoke-free future and understand that we can get there faster if regulators and the public health community embrace a more contemporary and science-driven approach–one that encourages innovation and invites open collaboration.
Crucially, society expects nothing less. The latest survey shows a significant majority (73 percent) of respondents want governments to consider the role alternative products can play in making their country smoke-free. In contrast, just one in four respondents agreed that more regulation on cigarettes is all that is needed to achieve this. Overall, 71 percent of the people surveyed agree that encouraging men and women who would otherwise continue to smoke cigarettes to completely switch to smoke-free alternatives can complement other efforts to reduce the societal harm caused by cigarettes.
We have transformed our business to deliver a smoke-free future and understand that we can get there faster if regulators and the public health community embrace a more contemporary and science-driven approach—one that encourages innovation and invites open collaboration.
It’s because of innovations in science and technology that these products exist today and a future without cigarettes is possible. And we, as a society, can affect the speed at which we’ll get there.
For PMI, our objective, path, and pace are clear. We’ve made the decision to focus our resources on developing, scientifically substantiating, and responsibly commercializing smoke-free products, with the aim of completely replacing cigarettes as soon as possible. In fact, we believe that with the right regulatory encouragement and support from civil society, cigarette sales can end within 10 to 15 years in many countries.
As a year of defining decisions for public health, 2021 could also define how fast we can eradicate smoking. With the ninth Conference of the Parties of the WHO Framework Convention on Tobacco Control convening in November, there is an opportunity for governments to assess the science behind smoke-free alternatives, examine the facts, and decide how best to respond to society’s demand for a new approach that enables the men and women who would otherwise continue to smoke make better choices for themselves.
To be clear, the best choice for people who smoke is to quit cigarettes and nicotine altogether. And of course, the efforts to protect minors from smoking, prevent initiation, and promote cessation must continue to be a priority. But we cannot deny those adults who don’t quit the opportunity to switch to better alternatives.
Better choices for people who would otherwise continue to smoke exist. So, the crucial question now is how quickly we can turn this opportunity for progress into reality for the hundreds of millions of adult smokers in the world today. I am convinced that to get to a smoke-free future faster, we need to let science lead and encourage fact-based conversations that are transparent and inclusive of all stakeholders who can contribute to change. If our shared experience this past year has taught us anything, it is that in the face of a pressing problem there’s neither time to waste, nor room for ideologies and unsubstantiated beliefs. Solutions are born out of facts, collaboration, and open minds.